Tempest Therapeutics, Inc. (TPST) stock
TPSTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.33−0.01 (-4.24%)
Close on Nov 17, 2026Market cap $4.85MP/E –Yield –
Tempest Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Tempest Therapeutics's price to book ratio was 14.9× on Jul 31, 2026, against 2.3× a year earlier. Over the last 5 years it ranged from 0.5× to 37.3×, with a median of 1.9×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Jul 31, 2026 | 14.9× | +12.9 |
| 2025 | Dec 31, 2025 | 2.0× | +0.1 |
| 2024 | Dec 31, 2024 | 1.9× | −8.4 |
| 2023 | Oct 31, 2023 | 10.3× | +9.8 |
| 2022 | Dec 30, 2022 | 0.5× | −1.2 |
| 2021 | Oct 29, 2021 | 1.6× | −35.6 |
| 2020 | Jan 31, 2020 | 37.3× | +5.6 |
| 2019 | Dec 31, 2019 | 31.6× | +29.7 |
| 2018 | Dec 31, 2018 | 1.9× | −1.2 |
| 2017 | Dec 29, 2017 | 3.1× | +1.2 |
| 2016 | Dec 30, 2016 | 1.9× | −6.5 |
| 2015 | Dec 31, 2015 | 8.4× | −60.6 |
| 2014 | Dec 31, 2014 | 69.0× | +54.6 |
| 2013 | Dec 31, 2013 | 14.3× | +0.7 |
| 2012 | Dec 31, 2012 | 13.6× | – |
See a number that looks wrong?